Sage Therapeutics Inc (FRA:SG7)
€ 10.175 -0.385 (-3.65%) Market Cap: 589.40 Mil Enterprise Value: -65.07 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 49/100

SAGE Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 09:20PM GMT
Release Date Price: €47 (+1.29%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

Good afternoon. Thanks for taking time to sit it in, in our next session here at the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the senior SMID biotech analysts here. It's my pleasure to have our next presenting company here with me, Sage Therapeutics.

There are several members from the management team on stage with me. So I'll introduce. Just to my left, Kimi Iguchi, who is, of course, CFO of the company. And then, Kimi, you may introduce your other colleagues.

Kimi E. Iguchi
Sage Therapeutics, Inc. - CFO & Treasurer

Chris Benecchi, Chief Business Officer; and Al Robichaud, Chief Scientific Officer.

Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst

So thank you all for making the trip out west. We really appreciate it. So we usually ask all companies to do a 2-minute elevator pitch. And so there's a lot going on at Sage. Well I'm sure

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot